Reports have shown diagnostic and prognostic uses of KLK10 in ovarian cancer (Shvartsman et al, 2003), and as such, it represents a possible therapeutic target for metastatic ovarian cancer. This evidence concerns the gene KLK10 and ovarian cancer.